The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

All agenciesFDA (Food)FDA (Drugs)FDA (Devices)USDA FSISCPSCNHTSAEPA

Category

All categoriesFoodDrugMedical DeviceVehicleConsumer Product

Minimum severity

Any3+ (High and above)4+ (High and above)5+ (High and above)

Clear filters

14951–14975 of 18042

  • LowFDA (Drugs)·D-0052-2015·2014-11-05

    Valeant Recalls APLENZIN Tablets Due to Missing Package Insert

    Valeant Pharmaceuticals is recalling APLENZIN extended-release tablets because the package insert is incorrect or missing. Consumers should contact their healthcare provider.

    Product
    APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 348 mg, a) 7-count HDPE bottle (NDC 0024-5811-07), b) 30-count HDPE bottle (NDC 0024-5811-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0053-2015·2014-11-05

    Valeant Recalls APLENZIN Tablets Due to Missing Package Insert

    Valeant Pharmaceuticals is recalling APLENZIN (bupropion hydrobromide) extended-release tablets because the package insert is incorrect or missing.

    Product
    APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 522 mg, a) 7-count HDPE bottle (NDC 0024-5812-07), b) 30-count HDPE bottle (NDC 0024-5812-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0051-2015·2014-11-05

    Valeant Recalls APLENZIN Tablets Due to Missing Package Insert

    Valeant Pharmaceuticals is recalling 20,499 bottles of APLENZIN (bupropion hydrobromide) 174 mg tablets because the package insert is incorrect or missing.

    Product
    APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 174 mg, 7-count HDPE bottle, Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7, NDC 0024-5810-07.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0038-2015·2014-10-29

    Qualitest Recalls Children's Acetaminophen Suspension for Assay Failure

    Qualitest Pharmaceuticals is recalling specific lots of Children's Q-PAP Acetaminophen Oral Suspension because the product failed an assay test at the 12-month timepoint.

    Product
    CHILDREN'S Q-PAP, Acetaminophen, ORAL SUSPENSION, CHERRY FLAVOR, Active ingredient (in each 5 mL = 1 tsp) Acetaminophen USP 160 mg, 4 FL OZ (118 mL), Made in the USA for Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-0842-54, OTC
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0039-2015·2014-10-29

    Qualitest Recalls Children's Acetaminophen Suspension for Assay Failure

    Qualitest Pharmaceuticals is recalling Children's Q-PAP Acetaminophen Oral Suspension due to a failure of the product assay at the 12-month timepoint.

    Product
    CHILDREN'S Q-PAP, Acetaminophen, ORAL SUSPENSION, GRAPE FLAVOR, Active ingredient (in each 5 mL = 1 tsp) Acetaminophen USP 160 mg, 4 FL OZ (118 mL), Made in the USA for Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-0843-54, OTC
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0037-2015·2014-10-29

    Qualitest Recalls Children's Acetaminophen Suspension for Assay Failure

    Qualitest Pharmaceuticals is recalling Children's Q-PAP Acetaminophen Oral Suspension because the product failed an assay test at the 12-month timepoint.

    Product
    CHILDREN'S Q-PAP, Acetaminophen, ORAL SUSPENSION, BUBBLE GUM FLAVOR, Active ingredient (in each 5 mL = 1 tsp) Acetaminophen USP 160 mg, 4 FL OZ (118 mL), Made in the USA for Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-0841-54, OTC
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0040-2015·2014-10-29

    American Family Pharmacy Recalls Subpotent Aspirin Tablets

    American Family Pharmacy is recalling 4.2 million bottles of Assured Aspirin 81 mg tablets because they failed to meet USP specifications for potency and uniformity.

    Product
    Assured Aspirin Enteric Safety Coated Tablets, 81 mg, Adult Low Strength, Pain Reliever (NSAID), 60-count bottle, Distributed by Greenbrier International, Inc., Chesapeake, VA 23320 UPC 639277018328.
    Category
    Drug
    Distribution
    3 states
  • SevereFDA (Drugs)·D-0042-2015·2014-10-29

    Ciprofloxacin 500 mg Tablets Recalled Due to Foreign Tramadol Tablets

    Aidarex Pharmaceuticals is recalling Ciprofloxacin 500 mg tablets because Tramadol 50 mg tablets were found in the bottles.

    Product
    Ciprofloxacin 500 mg tablets, 20 count bottle, Rx only, Packaged by Aidarex Pharmacecuticals LLC, MFG: Unique Pharmaceutical Laboratories, Mumbai, India
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0044-2015·2014-10-29

    Hospira Recalls Hydromorphone Hydrochloride Injection Due to Broken Vials

    Hospira Inc. is recalling 145,600 vials of Hydromorphone Hydrochloride Injection because customer complaints confirmed that some glass vials may be broken or cracked, compromising sterility.

    Product
    HYDROMORPHONE HYDROCHLORIDE — HYDROMORPHONE HYDROCHLORIDE (HYDROMORPHONE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D0035-2015·2014-10-29

    New Gpc Inc. Recalls Rector's Remedy Ointment for Labeling Deficiencies

    New Gpc Inc. is recalling Rector's Remedy Ointment because the product lacks required drug listings and OTC labeling.

    Product
    Rector's Remedy OINTMENT, Net Contents: 15g. Manufactured by: NEW GPC INC. A1 Farm, EBD. Country of Origin Guyana.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D0033-2015·2014-10-29

    New GPC Inc. Recalls Whitfield Lotion for Labeling Deficiencies

    New GPC Inc. is recalling 360 units of Whitfield Lotion in New York because the product lacks required OTC drug listing and labeling.

    Product
    WHITFIELD LOTION, Net Contents: 60 mL. Manufactured by: NEW GPC INC. A1 Farm, EBD. Country of Origin Guyana.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D0032-2015·2014-10-29

    New GPC Inc. Recalls Ferrol Expectorant for Labeling Deficiencies

    New GPC Inc. is recalling Ferrol Expectorant because the product lacks required OTC drug listings and labeling, and is labeled as not approved for sale in the U.S.

    Product
    Ferrol EXPECTORANT, Net Contents: 100 mL. Product packaged within a plastic bottle individually placed in small blue carton. Manufactured by: NEW GPC INC. A1 Farm, EBD. Country of Origin Guyana.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0028-2015·2014-10-29

    Bio-Pharm Recalls Acetaminophen Oral Suspension Due to Assay Failure

    Bio-Pharm, Inc. is recalling one lot of Acetaminophen Oral Suspension Liquid 160mg/5mL because the product failed the assay at the 6-month timepoint.

    Product
    Rugby Children's Pain and Fever Acetaminophen Oral Suspension 160 mg/5 mL, Cherry Flavor, 2 FL. oz bottle, OTC, Distributed by: Rugby Laboratories Livonia, MI 48150, NDC 0536-3606-96 Major Children's Mapap Suspension Liquid, Cherry Flavor, 4 FL OZ bottle, OTC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0036-2015·2014-10-29

    Forest Pharmaceuticals Recalls Bystolic Tablets for Dissolution Failure

    Forest Pharmaceuticals is recalling Bystolic (nebivolol) 20 mg tablets because they failed a dissolution specification at a 6-month stability time point.

    Product
    Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D0029-2015·2014-10-29

    New GPC Inc. Recalls Alcosulph Moisturizing Cream for Labeling Deficiencies

    New GPC Inc. is recalling Alcosulph Moisturizing Cream because it lacks required OTC drug listings and labeling, and is marked not approved for sale in the U.S.

    Product
    alcosulph Moisturizing Cream, Net Contents: 60g. Product packaged within a plastic container individually placed in small carton. Country of Origin Guyana.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D0031-2015·2014-10-29

    New Gpc Inc. Recalls Mustarcreme for Labeling and Listing Deficiencies

    New Gpc Inc. is recalling Mustarcreme units in New York because the product lacks required drug listings, OTC labeling, and is marked not approved for U.S. sale.

    Product
    MUSTARCREME, Net Contents: 60g (21 oz) Country of Origin Guyana.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0041-2015·2014-10-29

    ZEE Aspirin Recalled for Incorrect Inactive Ingredient Labeling

    ZEE Medical is recalling ZEE Aspirin 325mg tablets because the product label incorrectly lists inactive ingredients.

    Product
    ZEE Aspirin 325mg - 24 tablets in single dose packets, OTC, Manufactured for ZEE Medical Inc., Irvine,CA 92606 by ULTRA Tab Laboratories, Inc. Highland, NY 12528
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D0034-2015·2014-10-29

    New GPC Inc. Recalls Whitfield's Ointment for Labeling Deficiencies

    New GPC Inc. is recalling 4,320 units of Whitfield's Ointment B.P. in New York due to missing drug listings and non-compliant labeling.

    Product
    Whitfield's OINTMENT B.P., Net Contents: 15g. Manufactured by: NEW GPC INC. A1 Farm, EBD. Country of Origin Guyana.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D0030-2015·2014-10-29

    New GPC Inc. Recalls Alcosulph Astringent Lotion for Labeling Deficiencies

    New GPC Inc. is recalling Alcosulph Astringent Lotion because it lacks required drug listings and OTC labeling, and is labeled as not approved for sale in the U.S.

    Product
    alcosulph Astringent Lotion, Net Contents: 1) 60 mL and 2) 120 mL. Product packaged within a glass container individually placed in small carton. Country of Origin Guyana.
    Category
    Drug
    Distribution
    1 state
  • LowFDA (Drugs)·D-0043-2015·2014-10-29

    American Health Packaging Recalls Subpotent Methylprednisolone Tablets

    American Health Packaging is recalling 2,005 cartons of Methylprednisolone 4 mg tablets because they failed to meet potency standards at a 6-month stability time point.

    Product
    METHYLPREDNISOLONE — METHYLPREDNISOLONE (METHYLPREDNISOLONE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0020-2015·2014-10-22

    Hospira Recalls Lidocaine Hydrochloride Vials Due to Particulate Matter

    Hospira is recalling 109,110 vials of Lidocaine Hydrochloride Injection because the product was discolored and contained visible particulates.

    Product
    LIDOCAINE HYDROCHLORIDE — LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0025-2015·2014-10-22

    Valeant Recalls Subpotent Hydrocortisone Butyrate Cream 0.1% Tubes

    Valeant Pharmaceuticals is recalling 34,218 tubes of Hydrocortisone Butyrate Cream 0.1% because the product failed stability testing for potency and preservative levels.

    Product
    Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for: Rouses Point Pharmaceuticals, LLC Cranford, NJ 07016 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 43478-270-15
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0026-2015·2014-10-22

    Valeant Recalls Subpotent Locoid Hydrocortisone Butyrate Cream Tubes

    Valeant Pharmaceuticals is recalling 1,663 tubes of Locoid cream because the active ingredient and preservatives were subpotent at the 18-month stability test point.

    Product
    Locoid (hydrocortisone butyrate 0.1%), Cream, Net Wt. 15 gm tubes, Rx only, Manufactured for: Onset Dermatologics, LLC, Cumberland, RI 02864 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 16781-382-15
    Category
    Drug
    Distribution
    Distributed nationwide